Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 7 January 2014
Vol. 7, Issue 307, p. ra2
[DOI: 10.1126/scisignal.2004207]


Editor's Summary

Blocking Oncogenic Receptor Cleavage
The surface receptor for transforming growth factor–β (TGFβ) can be cleaved, generating a fragment of the receptor containing the intracellular domain that enters the nucleus and mediates transcription of genes that encode tumor-promoting factors. Gudey et al. found that presenilin 1, a component of the {gamma}-secretase complex, which cleaves various transmembrane proteins, also targeted the TGFβ receptor. TGFβ treatment increased the abundance and activity of presenilin 1 and the production of the receptor intracellular domain, which transcriptionally activated genes involved in invasion and metastasis. Treatment of mice bearing tumors formed from prostate cancer cells with a {gamma}-secretase inhibitor decreased the production of the intracellular domain of the TGFβ receptor and tumor growth. Thus, blocking {gamma}-secretase activity could attenuate the tumor-promoting effects of TGFβ signaling and decrease the growth of prostate tumors.

Citation: S. K. Gudey, R. Sundar, Y. Mu, A. Wallenius, G. Zang, A. Bergh, C.-H. Heldin, M. Landström, TRAF6 Stimulates the Tumor-Promoting Effects of TGFβ Type I Receptor Through Polyubiquitination and Activation of Presenilin 1. Sci. Signal. 7, ra2 (2014).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882